STOCK TITAN

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

INOVIO (NASDAQ:INO) announced its Q3 2025 financial results will be released after market close on November 10, 2025.

The company will host a live conference call and webcast at 4:30 p.m. ET the same day to discuss results and provide a business update. The webcast is listen-only with a live Q&A with analysts and will be archived for 90 days at the company investor site.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 12 Alerts

+6.87% News Effect
+9.5% Peak in 48 min
+$9M Valuation Impact
$142M Market Cap
1.1x Rel. Volume

On the day this news was published, INO gained 6.87%, reflecting a notable positive market reaction. Argus tracked a peak move of +9.5% during that session. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $9M to the company's valuation, bringing the market cap to $142M at that time.

Data tracked by StockTitan Argus on the day of publication.

PLYMOUTH MEETING, Pa., Oct. 27, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases, today announced that its third quarter 2025 financial results will be released after the market close on November 10, 2025. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss the financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancers, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, investor.relations@inovio.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-third-quarter-2025-financial-results-on-november-10-2025-302594838.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO (INO) release its Q3 2025 financial results?

INOVIO will release Q3 2025 results after market close on November 10, 2025.

What time is the INOVIO (INO) Q3 2025 earnings webcast on November 10, 2025?

The live conference call and webcast begins at 4:30 p.m. ET on November 10, 2025.

Where can investors watch the INOVIO (INO) Q3 2025 webcast?

The webcast will be available at http://ir.inovio.com/events-and-presentations/default.aspx.

Will there be a Q&A during INOVIO's (INO) November 10, 2025 webcast?

Yes. The event is listen-only but will include a live Q&A with analysts.

How long will the INOVIO (INO) webcast archive be available after the November 10, 2025 event?

The webcast will be archived and available for replay for 90 days after the event.

What will INOVIO (INO) cover during the November 10, 2025 call?

The company will discuss its Q3 2025 financial results and provide a general business update.
Inovio Pharmaceu

NASDAQ:INO

INO Rankings

INO Latest News

INO Latest SEC Filings

INO Stock Data

109.93M
68.42M
0.51%
19.04%
12.41%
Biotechnology
Pharmaceutical Preparations
Link
United States
PLYMOUTH MEETING